|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.37 EGP | -7.06% |
|
-18.28% | -24.52% |
| Mar. 03 | Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Feb. 05 | Ibnsina Pharma(CASE:ISPH) added to EGX 30 Index | CI |
Ibnsina Pharma reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was EGP 22,264.5 million compared to EGP 21,732.83 million a year ago. Net income was EGP 172.58 million compared to EGP 314.73 million a year ago.
Basic earnings per share from continuing operations was EGP 0.13 compared to EGP 0.2229 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -24.52% | 49.93M | |
| -33.59% | 15.3B | |
| -24.81% | 11.07B | |
| +9.74% | 6.13B | |
| -10.95% | 5.95B | |
| +0.88% | 4.79B | |
| +53.60% | 4.36B | |
| -10.49% | 3.69B | |
| -12.53% | 3.43B | |
| -6.87% | 3.05B |
IBNSINA PHARMA 
